32 results on '"Susanne Wendt"'
Search Results
2. Einmalige perioperative Ceftriaxon-Prophylaxe ist ausreichend bei Cochlea-Implantationen bei Erwachsenen
- Author
-
Stefan Lyutenski, Susanne Wendt, Nina Zellhuber, Paul James, and Marc Bloching
- Published
- 2022
- Full Text
- View/download PDF
3. Phäohyphomykose durch Cladosporium cladosporioides bei einem immunsupprimierten Jungen mit Ewing‐Sarkom
- Author
-
Regina Treudler, Pietro Nenoff, Silke Uhrlaß, Jan-Christoph Simon, Dorothea Kratzsch, and Susanne Wendt
- Subjects
Dermatology - Published
- 2021
- Full Text
- View/download PDF
4. Phaeohyphomycosis caused by Cladosporium cladosporioides in an immunosuppressed boy with Ewing sarcoma
- Author
-
Pietro Nenoff, Jan-Christoph Simon, Susanne Wendt, Silke Uhrlaß, Regina Treudler, and Dorothea Kratzsch
- Subjects
Male ,medicine.medical_specialty ,biology ,business.industry ,Cladosporium cladosporioides ,Dermatology ,Sarcoma, Ewing ,biology.organism_classification ,medicine.disease ,Phaeohyphomycosis ,medicine ,Dermatomycoses ,Humans ,Sarcoma ,business ,Cladosporium - Published
- 2021
5. XV. Beschreibungen ausgewählter Fachsprachen II: technische Fachsprachen des Deutschen und Fachsprachen angewandter Wissenschaften im 19. und 20. Jahrhundert
- Author
-
Jürgen Bast, Khai Le-Hong, Peter A. Schmitt, Christiane Unger, Sigurd Wichter, Axel Satzger, Susanne Wendt, Gerhard Freibott, Katharina Grewe, Ulrich Heid, Günter Schnegelsberg, Lothar Hums, and Kurt Opitz
- Published
- 2020
- Full Text
- View/download PDF
6. PRL-3 Mediates the Protein Maturation of ULBP2 by Regulating the Tyrosine Phosphorylation of HSP60
- Author
-
Wai-Hang Leung, Wing Leung, Ying Li, David Bouck, Taosheng Chen, Queenie P. Vong, Susanne Wendt, Wenwei Lin, Erin Sullivan, and Rafijul Bari
- Subjects
Blotting, Western ,Immunology ,Phosphatase ,Cell ,Matrix Metalloproteinase Inhibitors ,Biology ,Endoplasmic Reticulum ,GPI-Linked Proteins ,Article ,chemistry.chemical_compound ,Cell Line, Tumor ,medicine ,Humans ,Immunology and Allergy ,Cytotoxic T cell ,Enzyme Inhibitors ,Phosphorylation ,Protein maturation ,Cells, Cultured ,Gene knockdown ,Microscopy, Confocal ,Reverse Transcriptase Polymerase Chain Reaction ,Tyrosine phosphorylation ,Chaperonin 60 ,Dipeptides ,HCT116 Cells ,Molecular biology ,Neoplasm Proteins ,Cell biology ,Gene Expression Regulation, Neoplastic ,Immunosurveillance ,HEK293 Cells ,medicine.anatomical_structure ,ULBP2 ,chemistry ,Intercellular Signaling Peptides and Proteins ,Tyrosine ,RNA Interference ,Protein Tyrosine Phosphatases ,HT29 Cells ,HeLa Cells ,Protein Binding - Abstract
Many malignant cells release the NKG2D ligand ULBP2 from their cell surface to evade immunosurveillance by NK cells and CD8 T cells. Although the shedding mechanism remains unclear, various inhibitors of matrix metalloproteinases have been shown to efficiently block the release of soluble ULBP2. The clinical use of these inhibitors, however, is limited because of adverse side effects. Using high-throughput screening technique, we identified a specific inhibitor of phosphatase of regenerating liver 3 (PRL-3) that could reduce the level of soluble ULBP2 in the culture supernatant of various cancer cell lines. Inhibition or gene knockdown of PRL-3 did not reduce ULBP2 shedding, but rather suppressed posttranslational maturation of ULBP2, resulting in intracellular retention of immature ULBP2. We then found that ULBP2 was constitutively associated with heat shock protein HSP60. Complete maturation of ULBP2 required tyrosine phosphorylation of HSP60 which was mediated by PRL-3.
- Published
- 2015
- Full Text
- View/download PDF
7. Die Rolle des Portfoliomanagements im Rahmen des strategischen Managements
- Author
-
Wolfgang Becker and Susanne Wendt-Meyer
- Published
- 2014
- Full Text
- View/download PDF
8. Neoplastic causes of abnormal puberty
- Author
-
Susanne Wendt, John Shelso, Wayne L. Furman, and Karen Wright
- Subjects
Hepatoblastoma ,Pediatrics ,medicine.medical_specialty ,Pathology ,business.industry ,Childhood cancer ,Follow up studies ,Brain tumor ,Cancer ,Hematology ,medicine.disease ,Pediatric cancer ,Oncology ,Pediatrics, Perinatology and Child Health ,medicine ,Adrenocortical carcinoma ,Precocious puberty ,business - Abstract
Background Neoplasm-related precocious puberty (PP) is a rare presenting feature of childhood cancer. Moreover, evaluation of suspected PP in a child is complex, and cancer is often not considered. We characterized the clinicopathologic features of patients presenting with PP at a large pediatric cancer center, reviewed the relevant literature, and developed an algorithm for the diagnostic work-up of these patients.
- Published
- 2013
- Full Text
- View/download PDF
9. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
- Author
-
Joseph, Muenzer, James E, Wraith, Michael, Beck, Roberto, Giugliani, Paul, Harmatz, Christine M, Eng, Ashok, Vellodi, Rick, Martin, Uma, Ramaswami, Muge, Gucsavas-Calikoglu, Suresh, Vijayaraghavan, Susanne, Wendt, Suzanne, Wendt, Ana Cristina, Puga, Antonio, Puga, Brian, Ulbrich, Marwan, Shinawi, Maureen, Cleary, Diane, Piper, Anne Marie, Conway, Ann Marie, Conway, and Alan, Kimura
- Subjects
Adult ,Male ,Vital capacity ,medicine.medical_specialty ,Adolescent ,Idursulfase ,Vital Capacity ,Iduronate Sulfatase ,Placebo ,law.invention ,chemistry.chemical_compound ,Double-Blind Method ,Randomized controlled trial ,Elosulfase alfa ,law ,Internal medicine ,medicine ,Humans ,Mucopolysaccharidosis type II ,Child ,Genetics (clinical) ,Glycoproteins ,Mucopolysaccharidosis II ,business.industry ,Hunter syndrome ,Drug Tolerance ,Enzyme replacement therapy ,medicine.disease ,Recombinant Proteins ,Surgery ,chemistry ,Child, Preschool ,Safety ,business ,medicine.drug - Abstract
Purpose: To evaluate the safety and efficacy of recombinant human iduronate-2-sulfatase (idursulfase) in the treatment of mucopolysaccharidosis II. Methods: Ninety-six mucopolysaccharidosis II patients between 5 and 31 years of age were enrolled in a double-blind, placebo-controlled trial. Patients were randomized to placebo infusions, weekly idursulfase (0.5 mg/kg) infusions or every-other-week infusions of idursulfase (0.5 mg/kg). Efficacy was evaluated using a composite endpoint consisting of distance walked in 6 minutes and the percentage of predicted forced vital capacity based on the sum of the ranks of change from baseline. Results: Patients in the weekly and every-other-week idursulfase groups exhibited significant improvement in the composite endpoint compared to placebo (P = 0.0049 for weekly and P = 0.0416 for every-other-week) after one year. The weekly dosing group experienced a 37-m increase in the 6-minute-walk distance (P = 0.013), a 2.7% increase in percentage of predicted forced vital capacity (P = 0.065), and a 160 mL increase in absolute forced vital capacity (P = 0.001) compared to placebo group at 53 weeks. Idursulfase was generally well tolerated, but infusion reactions did occur. Idursulfase antibodies were detected in 46.9% of patients during the study. Conclusion: This study supports the use of weekly infusions of idursulfase in the treatment of mucopolysaccharidosis II.
- Published
- 2006
- Full Text
- View/download PDF
10. Strategisches Portfoliomanagement in dynamischen Technologiemärkten : Entwicklung einer Portfoliomanagement-Konzeption für TIME-Unternehmen
- Author
-
Susanne Wendt and Susanne Wendt
- Subjects
- Investment analysis, Asset allocation, Portfolio management, Business enterprises--Finance, Corporations--Finance
- Abstract
Etablierte Unternehmen in den TIME-Branchen (Telekommunikation, Informationstechnologie sowie Medien und Entertainment) müssen mittelfristig aufgrund dynamischer Marktentwicklungen zunehmend sinkende Erfolgsbeiträge in Kerngeschäftsfeldern kompensieren und neue Erfolgspotentiale erschließen. Ein ganzheitliches Portfoliomanagement kann Unternehmen unterstützen, ihre Portfolios grundlegend neu zu gestalten und an den veränderten Rahmenbedingungen auszurichten. Aufbauend auf theoretischen und empirischen Erkenntnissen wird im Rahmen der Arbeit eine holistische Portfoliomanagement-Konzeption zur ganzheitlichen Bewertung und Steuerung unternehmerischer Produkt-Markt-Aktivitäten entwickelt. Neben dem prozessualen Vorgehen werden Instrumente und Methoden vorgestellt und konkrete Implementierungsempfehlungen zur organisatorischen Einbettung gegeben, damit der Einsatz des Portfoliomanagement optimal auf die Sicherung von Unternehmenserfolg und -stabilität einzahlen kann.
- Published
- 2013
11. Response: should initial investigations for neoplastic causes of precocious puberty include serum beta-human chorionic gonadotropin and alpha-fetoprotein?
- Author
-
Susanne, Wendt, Karen, Wright, and Wayne L, Furman
- Subjects
Male ,Neoplasms ,Humans ,Puberty, Precocious ,Female - Published
- 2014
12. The influence of stocking rate on transmission of helminth parasites in pigs on permanent pasture during two consecutive summers
- Author
-
L.E. Thomsen, Allan Roepstorff, Ole Hindsbo, Susanne Wendt, and Helena Mejer
- Subjects
Male ,Veterinary medicine ,Swine ,Denmark ,Poaceae ,Pasture ,Feces ,Animal science ,Stocking ,Helminths ,parasitic diseases ,Grazing ,Animals ,Animal Husbandry ,Parasite Egg Count ,Ascaris suum ,Swine Diseases ,geography ,geography.geographical_feature_category ,General Veterinary ,biology ,Inoculation ,Body Weight ,Trichuris suis ,General Medicine ,biology.organism_classification ,Nematode ,Female ,Parasitology ,Helminthiasis, Animal - Abstract
This study was made to elucidate the transmission of nematode infections in outdoor pigs at different stocking rates during two consecutive seasons. Five pigs (Group 1A) inoculated with low doses of Oesophagostomum dentatum, Ascaris suum, and Trichuris suis and five helminth-naïve pigs (Group 1B) were turned out together in June 1996 on each of four pastures at stocking rates of 100, 240 (two pastures) and 576m(2) per pig, respectively. The pigs were slaughtered in early October, and pasture infectivity was subsequently measured using helminth-naïve tracer pigs (Tracer). In 1997, 10 helminth-naïve pigs were turned out on each pasture in May (Group 2) and again in August (Group 3), and allowed to graze for 12 weeks. The percentage of grass cover was reduced considerably at the high stocking rate in comparison to the other stocking rates. Transmission of all three helminths was observed on all pastures. In 1996, the O. dentatum faecal egg counts and worm burdens were significantly higher in pigs at the high stocking rate compared to pigs at the other stocking rates. O. dentatum did not survive the winter and pigs of Group 2 were inoculated with 3000 larvae each to reintroduce this parasite. Ascaris suum ELISA values and worm counts were highest at the high stocking rate in 1997 (Group 3). Transmission of T. suis was not significantly influenced by stocking rate. The results indicate that transmission of O. dentatum, and to some extent A. suum is influenced by stocking rate. However, both A. suum and T. suis eggs are still expected to constitute a high risk of infection on intensively used pastures where eggs may accumulate for years. The relationship between host density and helminth transmission seems more complex for grazing/rooting pigs than for grazing ruminants. This may be due to the differences in behaviour of the animals and the resulting differences in microclimate of the developing eggs/larvae.
- Published
- 2001
- Full Text
- View/download PDF
13. [Untitled]
- Author
-
Ulrich Gärtner, Peter Wiedemann, Mike Francke, Frank Faude, Susanne Wendt, Andreas Reichenbach, Johannes Seeger, Johannes Kacza, and Felix Makarov
- Subjects
Retina ,Histology ,Retinal pigment epithelium ,General Neuroscience ,Phagocytosis ,Retinal detachment ,Retinal ,Cell Biology ,Biology ,medicine.disease ,Cell biology ,Melanin ,chemistry.chemical_compound ,medicine.anatomical_structure ,chemistry ,Cytoplasm ,medicine ,Ultrastructure ,sense organs ,Anatomy - Abstract
The ability of retinal Muller glial cells to perform phagocytosis in vivo is studied in a rabbit model of experimental retinal detachment where pigment epithelial cells are occasionally detached together with the neural retina. While macrophages and/or microglial cells phagocytoze most of the cellular debris at the sclerad surface of the detached retinae, some Muller cells accumulate melanin granules. The granules are virtually intact at the ultrastructural level, and are surrounded by a membrane. They are often located close to the sclerad end of the cells, but some are distributed throughout the outer stem process up to the soma. It is concluded that rabbit Muller cells in vivo are capable of phagocytosis and of transporting the phagocytozed material within their cytoplasm.
- Published
- 2001
- Full Text
- View/download PDF
14. Grundlagen des strategischen Portfoliomanagement
- Author
-
Susanne Wendt
- Abstract
In dem voran gegangenen Kapitel wurden die Entwicklungen in den TIME-Branchen und die daraus resultierenden Herausforderungen fur etablierte Branchenunternehmen dargestellt. Es wurde aufgezeigt, dass die bestehenden Produkte, Geschaftsmodelle und Geschaftsfelder in diesen Branchen revolutionaren Veranderungen ausgesetzt sind, die zu einer Storung des Wertschopfungskreislaufs und zu erfolgswirtschaftlichen Destabilisierungen der Branchenunternehmen fuhren konnen. Um diesen Herausforderungen zu begegnen, mussen etablierte Unternehmen Handlungsstrategien fur die Sicherung, den Aufbau und die Gestaltung ihrer Produkt-Markt-Aktivitaten entwickeln, um auch zukunftig Erfolg und Stabilitat zu gewahrleisten. Dies ist eine Aufgabe des Portfoliomanagement, dass in der Literatur als Instrument des strategischen Management fur die Bewertung und Planung bestehender und zukunftiger Produkt-Markt- Aktivitaten genannt wird.283
- Published
- 2013
- Full Text
- View/download PDF
15. Marktentwicklungen und strategische Herausforderungen in den TIME-Branchen
- Author
-
Susanne Wendt
- Abstract
Die Restrukturierung der als TIME bezeichneten Branchen Telekommunikation, Informationstechnologie sowie Medien- und Entertainment ist ein von Praktikern und Wissenschaftlern viel diskutiertes Phanomen. Wissenschaftliche Arbeiten zur Untersuchung der Entwicklungen sowie Management-Literatur mit Empfehlungen zum Umgang mit dem Wandel wurden vor allem in der Grundungs-Phase der so genannten „New Economy“62 veroffentlicht.63 Mit dem Platzen der „Dot.com-Blase“64 nahmen auch die Untersuchungen dieser Branchenveranderungen ab, insbesondere Praktiker sahen die Entwicklungen als vernachlassigbar an.65
- Published
- 2013
- Full Text
- View/download PDF
16. Fazit und Ausblick
- Author
-
Susanne Wendt
- Published
- 2013
- Full Text
- View/download PDF
17. Einführung und Grundlagen
- Author
-
Susanne Wendt
- Abstract
Die Branchen Telekommunikation, Informationstechnologie sowie Medien und Entertainment (kurz: TIME)1 haben sowohl weltweit als auch in Deutschland eine hohe wirtschaftliche Bedeutung. Im Jahr 2008 generierten die drei Branchen zusammengenommen einen Umsatz von rund 180 Mrd. €2 und beschaftigten ca. 1,3 Mio. Erwerbstatige in Deutschland.3 Ihre Bedeutung geht jedoch daruber hinaus. Die technologischen Weiterentwicklungen in Telekommunikation, Informationstechnologien und neuen Medien beeinflussen andere Wirtschaftszweige und pragen das Konsumentenverhalten nachhaltig. So hat der Ausbau breitbandiger Internetzugangstechnologien, die Durchdringung des Mobilfunks, die Verbreitung von Personal Computern sowie die Penetration des Internets in den letzten Jahrzehnten sowohl wirtschaftliche Prozesse und Arbeitswelten aber auch das private Umfeld und Konsumverhalten von Menschen nachhaltig verandert.4
- Published
- 2013
- Full Text
- View/download PDF
18. Portfoliomanagement in der Praxis von TIME-Unternehmen
- Author
-
Susanne Wendt
- Abstract
Trotz der umfangreichen Literatur zum Thema Portfoliomanagement existieren nur wenige empirische Studien zur Anwendung des Portfoliomanagement als Instrument des strategischen Management in der Praxis und nahezu keine Studien speziell zum Portfoliomanagement in TIME-Unternehmen. Uber Desk Research oder Meta- Analysen konnen aus diesem Grund kaum Erkenntnisse zur Anwendung und Bedeutung des Portfoliomanagement in den TIME-Branchen gewonnen werden. Um dem in Kapitel 1 dargelegten Anspruch einer Forschung im Gegenstrom gerecht zu werden, ist es jedoch wesentlich, neben theoretischen Uberlegungen auch Erkenntnisse aus der Praxis zu generieren.527 Daher erfolgt die Untersuchung des Portfoliomanagement in TIME-Unternehmen mittels einer eigenen empirischen Studie. Die Ergebnisse dieser Studie bilden zusammen mit den Erkenntnissen aus den Kapiteln 2 und 3 die Basis fur die in Kapitel 5 zu entwickelnde Portfoliomanagement-Konzeption.
- Published
- 2013
- Full Text
- View/download PDF
19. Strategisches Portfoliomanagement in dynamischen Technologiemärkten
- Author
-
Susanne Wendt
- Published
- 2013
- Full Text
- View/download PDF
20. Entwicklung einer Portfoliomanagement-Konzeption für die TIME-Branchen
- Author
-
Susanne Wendt
- Abstract
Im Verlauf dieses Kapitels erfolgt die Entwicklung einer Portfoliomanagement- Konzeption fur TIME-Unternehmen auf Basis der Erkenntnisse aus den vorangegangenen Betrachtungen. Hierbei werden sowohl die Strukturen und Veranderungen der TIME-Branchen, als auch die in der Theorie bestehenden Portfoliomanagement- Konzepte und die Anwendung des Portfoliomanagement in der Praxis von TIMEUnternehmen berucksichtigt. Die Arbeit auf den Erkenntnissen aus Theorie und Praxis aufzubauen, entspricht dem der vorliegenden Arbeit zugrunde liegenden Gedanken der Forschung im Gegenstrom.653 Zielsetzung dieses Vorgehen ist es, mit der Portfoliomanagement- Konzeption nicht nur ein theoretisches Konstrukt bereitzuste
- Published
- 2013
- Full Text
- View/download PDF
21. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- Author
-
Ana Cristina Puga, Alexandra Rossi, Joseph Muenzer, Marwan Shinawi, Ashok Vellodi, Rick A. Martin, Birgit Ulbrich, Michael Beck, Christine M. Eng, Susanne Wendt, Alan Kimura, Anne Marie Conway, James E. Wraith, Suresh Vijayaraghavan, Paul Harmatz, Uma Ramaswami, Muge Gucsavas-Calikoglu, Roberto Giugliani, Maureen Cleary, and David A.H. Whiteman
- Subjects
medicine.medical_specialty ,Vital capacity ,Adolescent ,Idursulfase ,Iduronate Sulfatase ,Pulmonary function testing ,Internal medicine ,Medicine ,Humans ,Enzyme Replacement Therapy ,Mucopolysaccharidosis type II ,Adverse effect ,Child ,Infusions, Intravenous ,Genetics (clinical) ,Glycosaminoglycans ,Mucopolysaccharidosis II ,business.industry ,Percent Predicted Forced Vital Capacity ,Hunter syndrome ,Enzyme replacement therapy ,Organ Size ,medicine.disease ,Surgery ,Treatment Outcome ,Liver ,Child, Preschool ,business ,Spleen ,medicine.drug - Abstract
Purpose: This study evaluated the safety and effectiveness of long-term enzyme replacement therapy with idursulfase (recombinant human iduronate-2-sulfatase) in patients with Hunter syndrome. Methods: All 94 patients who completed a 53-week double-blinded study of idursulfase enrolled in this open-labeled extension study and received intravenous idursulfase at a dose of 0.5 mg/kg weekly for 2 years, and clinical outcomes and safety were assessed. Results: No change in percent predicted forced vital capacity was seen, but absolute forced vital capacity demonstrated sustained improvement and was increased 25.1% at the end of the study. Statistically significant increases in 6-minute walking test distance were observed at most time points. Mean liver and spleen volumes remained reduced throughout the 2-year extension study. Mean joint range of motion improved for the shoulder and remained stable in other joints. Both the parent- and child-assessed Child Health Assessment Questionnaire Disability Index Score demonstrated significant improvement. Infusion-related adverse events occurred in 53% of patients and peaked at Month 3 of treatment and declined thereafter. Neutralizing IgG antibodies were detected in 23% of patients and seemed to attenuate the improvement in pulmonary function. Conclusions: Weekly infusions of idursulfase result in sustained clinical improvement during 3 years of treatment.
- Published
- 2010
22. Imipenem Resistance in Acinetobacter baumanii Is Due to Altered Penicillin-Binding Proteins
- Author
-
Max Gehrlein, Wolfgang Cullmann, H Leying, Wolfgang Opferkuch, and Susanne Wendt
- Subjects
Pharmacology ,Imipenem ,Penicillin binding proteins ,Molecular mass ,biology ,Clone (cell biology) ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,Acinetobacter ,biology.organism_classification ,Microbiology ,Infectious Diseases ,Oncology ,Drug Discovery ,polycyclic compounds ,medicine ,Pharmacology (medical) ,Neisseriaceae ,Bacterial outer membrane ,Antibacterial agent ,medicine.drug - Abstract
The comparison of a clinical Acinetobacter baumanii isolate (strain No. 4852/88) and its selected imipenem-resistant (IMR) clone exhibited a complex reorganization of the penicillin-binding proteins (PBPs) with diminished labelling of all PBPs except the 24-kD PBP which showed an increased binding of 14C-penicillin. This protein could not be saturated by preincubation of membranes with imipenem at 8-fold the MIC of imipenem, thus indicating PBP alterations responsible for imipenem resistance. In A. baumanii 4852/88 seven PBPs with the apparent molecular weights of 94, 84, 65, 61, 48, 40 and 24 kD could be detected. beta-Lactamase production was barely detectable in any case and could not be enhanced in the presence of various beta-lactams as the inducer. The outer membrane proteins were found identical in both the wild-type strain and the Im clone. So far, imipenem-resistant A. baumanii isolates have been isolated twice in our diagnostic laboratory; however, no implications on the future relevance of the above findings can be made.
- Published
- 1991
- Full Text
- View/download PDF
23. Contents, Vol. 37, 1991
- Author
-
G. Gardin, P. Rosso, Domenico Amoroso, Wolfgang Cullmann, Giovanni Bonfiglio, Susanne Wendt, Letizia Lombardini, Orietta Dal Pozzo, Gianfilippo Bertelli, A. Loscos, Edna Almodovar, T. Guido, P. A. Bernabei, H.R. Maurer, Gianluca D'Ippolito, J. Prieto, Silvia Fenigli, Joao da Fonseca, C. Pennucci, Roberto Mattina, Wolfgang Opferkuch, Paolo Pronzato, Ramona Kroschinsky, C. Ramos, Mark Burdette, H Leying, Max Gehrlein, F. Mínguez, S. Barrientos, H.T. Hassan, Pierluigi Rossi Ferrini, Clementina Cocuzza, Ursula Wolf, Tom Bergan, M. Cesana, Yoshio Ueno, G. Gulisano, Hussain Qadri, Walter H. Traub, B.P. Imbimbo, and Dierk Bauer
- Subjects
Pharmacology ,Infectious Diseases ,Oncology ,Drug Discovery ,Pharmacology (medical) ,General Medicine - Published
- 1991
- Full Text
- View/download PDF
24. Enzyme replacement therapy with agalsidase alfa in children with Fabry disease
- Author
-
Uma Ramaswami, F Santus, Mathias Beck, J A Leon Leal, Catharina Whybra, Susanne Wendt, Rossella Parini, and Guillem Pintos-Morell
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Globotriaosylceramide ,Sweating ,chemistry.chemical_compound ,Quality of life ,medicine ,Humans ,Brief Pain Inventory ,Adverse effect ,Child ,Pain Measurement ,business.industry ,Trihexosylceramides ,General Medicine ,Enzyme replacement therapy ,medicine.disease ,Fabry disease ,Recombinant Proteins ,Surgery ,Clinical trial ,Isoenzymes ,Treatment Outcome ,El Niño ,chemistry ,Child, Preschool ,alpha-Galactosidase ,Pediatrics, Perinatology and Child Health ,Fabry Disease ,Female ,business - Abstract
Aim: To assess the effects of enzyme replacement therapy (ERT) in children with Fabry disease. Methods: Safety and efficacy of ERT with agalsidase alfa, 0.2 mg/kg infused over 40 minutes every 2 weeks for 23 weeks, were studied in a multicentre open-label trial in nine boys and four girls. Median age at the start of the study was 11.0 years (range 3.5–18 years). Results: Fifty-four adverse events were reported in 11 patients. No serious adverse events related to ERT were reported. Twelve of the 54 adverse events were considered possibly or probably related to ERT. Infusion reactions (8 mild, 3 moderate) occurred in four boys, in seven infusions. One boy developed IgG antibodies, although he continued to make good clinical progress. At the end of the study, two of the four boys and the one girl on regular pain medication at baseline had stopped taking analgesics. Brief Pain Inventory (BPI) scores decreased in most patients by week 12 and were sustained until the end of the study. This change was greater in the boys, who had higher (worse) BPI scores at baseline. Pain-related quality of life (QoL) scores also decreased during the study. Plasma globotriaosylceramide concentrations and urinary globotriaosylceramide:sphingomyelin ratios decreased after 12 and 23 weeks of therapy, particularly in the boys. Increases in sweat volume were recorded in three out of five of the boys and in one of two girls tested after 23 weeks of treatment. Conclusion: ERT with agalsidase alfa in children with Fabry disease is well tolerated and, in the short term, appears to decrease pain and to improve pain-related QoL.
- Published
- 2006
25. Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa
- Author
-
E. Teichmann, Catharina Whybra, M Beck, C. Kampmann, and Susanne Wendt
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,medicine.medical_treatment ,Enzyme Therapy ,Pregnancy ,Genetics ,Lysosomal storage disease ,medicine ,Humans ,Genetics (clinical) ,Chemotherapy ,Vascular disease ,business.industry ,Infant, Newborn ,Pregnancy Outcome ,Enzyme replacement therapy ,medicine.disease ,Fabry disease ,Recombinant Proteins ,Surgery ,Isoenzymes ,Lysosomal Storage Diseases ,Pregnancy Complications ,Treatment Outcome ,alpha-Galactosidase ,Gestation ,Fabry Disease ,Female ,business ,Progressive disease - Abstract
Fabry disease is an inherited lysosomal storage disease caused by deficiency of alpha-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy.
- Published
- 2005
26. Response: Should initial investigations for neoplastic causes of precocious puberty include serum beta-human chorionic gonadotropin and alpha-fetoprotein?
- Author
-
Karen Wright, Susanne Wendt, and Wayne L. Furman
- Subjects
medicine.medical_specialty ,Endocrinology ,Oncology ,business.industry ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Precocious puberty ,Hematology ,Alpha-fetoprotein ,medicine.disease ,business ,Beta human chorionic gonadotropin - Published
- 2014
- Full Text
- View/download PDF
27. Nose-rings and transmission of helminth parasites in outdoor pigs
- Author
-
Susanne Wendt, Ole Hindsbo, Helena Mejer, Line Elnif Thomsen, and Allan Roepstorff
- Subjects
Male ,Swine ,Denmark ,Antibodies, Helminth ,Poaceae ,Pasture ,Article ,law.invention ,Feces ,Animal science ,law ,Seroepidemiologic Studies ,Helminths ,medicine ,Animals ,Trichuriasis ,Ascaris suum ,Parasite Egg Count ,Nose ,Infectivity ,Swine Diseases ,Oesophagostomum ,geography ,Ascariasis ,geography.geographical_feature_category ,General Veterinary ,biology ,Body Weight ,Trichuris suis ,General Medicine ,biology.organism_classification ,medicine.anatomical_structure ,Transmission (mechanics) ,Trichuris ,Equipment and Supplies ,Female ,Helminthiasis, Animal ,Oesophagostomiasis - Abstract
Mejer H, Wendt S, Thomsen LE, Roepstorff A, Hindsbo O: Nose-rings and transmission of helminth parasites in outdoor pigs. Acta vet. scand. 2000, 41, 153–165. – Five growing pigs experimentally infected with low doses of Oesophagostomum dentation, Ascaris suum, and Trichuris suis were turned out with 5 helminth-naive pigs on each of 3 pastures in June 1996 (Group 1). On one pasture all pigs received nose-rings. After slaughter of Group 1 in October, pasture infectivity was monitored using helminth-naive, unringed tracer pigs. In 1997, helminth-naive young pigs were turned out on the contaminated pastures in May (Group 2) and again in August (Group 3). Again all pigs on one pasture received nose-rings. All pigs and pastures were followed parasitologically and reduction in grass cover was monitored. Based on the acquisition of infection by the naive pigs in Group 1, the estimated minimal embryonation times for eggs deposited on pasture were 23–25 days for O. dentatum, 5–6 weeks for A. suum and 9–10 weeks for T. suis. Results from tracer pigs and grass/soil samples indicated that pasture infectivity was light both years. Free-living stages of O. dentatum did not survive the winter. The nose-rings reduced rooting considerably, resulting in three-fold more grass cover on the nose-ring pasture compared to the control pastures by the end of the experiment. Nevertheless, the nose-rings did not significantly influence parasite transmission.
- Published
- 2000
28. Correction: Corrigendum: Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- Author
-
Muge Gucsavas-Calikoglu, David A.H. Whiteman, Anne Marie Conway, Ashok Vellodi, James E. Wraith, Suresh Vijayaraghavan, Marwan Shinawi, Maureen Cleary, Alexandra Rossi, Roberto Giugliani, Michael Beck, Rick A. Martin, Birgit Ulbrich, Ana Cristina Puga, Christine M. Eng, Joseph Muenzer, Paul Harmatz, Alan Kimura, Susanne Wendt, and Uma Ramaswami
- Subjects
Veterinary medicine ,Pediatrics ,medicine.medical_specialty ,business.industry ,Idursulfase ,Extension study ,Hunter syndrome ,social sciences ,medicine.disease ,humanities ,behavior and behavior mechanisms ,medicine ,population characteristics ,business ,geographic locations ,Genetics (clinical) ,medicine.drug - Abstract
CORRIGENDUM: Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- Published
- 2013
- Full Text
- View/download PDF
29. Characterization of the Two Populations of NK-Like CD56+ T Cells and KIR+ T Cells in Human
- Author
-
Susanne Wendt, Piya Rujkijyanont, Rafijul Bari, Neha Das Gupta, Barbara Rooney, Martha Holladay, Wing Leung, Jie Yang, Geoffrey Neale, and Wing Keung Chan
- Subjects
T cell ,Immunology ,CD28 ,Priming (immunology) ,hemic and immune systems ,chemical and pharmacologic phenomena ,Cell Biology ,Hematology ,Biology ,NKG2D ,Biochemistry ,Molecular biology ,Interleukin 21 ,medicine.anatomical_structure ,medicine ,Cytokine secretion ,IL-2 receptor ,CD8 - Abstract
Abstract 3292 Previous studies have demonstrated that many T cell subsets possess NK-like features, including the CD56+ and KIR+ populations. Collectively, these studies showed that these NK-like T cells are predominantly αβ+ CD8+ with memory phenotype and could recognize HLA-E associated viral peptides after expansion upon TCR engagement. However, their clonality, transcriptome, regulation, specificity, and memory response in human have not been fully elucidated. We hypothesize that these NK-like T cells are phenotypically and functionally distinct from conventional T and NK cells and they play unique roles in virus and cancer control. Herein, we extensively characterized the CD56+ T cells and the KIR+ T subset by analysis of TREC, TCRVβ spectrum, telomere length, surface biomarkers, genome-wide transcriptome, multi-analyte cytokine profiling, cancer cell susceptibility, tetramer staining, and real-time response to CMV reactivation in stem cell transplant recipients. In contrast to CD56– T cells, CD56+ T cells are limited in TREC, TCRVβ, telomere length, cytokine secretion, transcription of metabolic genes stx6, nnt, galnt2, hvcn1, tyms, rpa1 tmf1, ecop, and tspan3, and are mostly KIR+, CD8+, DNAM1+, NKG2D+, CD44+, NKp46– and CD25–. Compared to KIR– CD56+ T cells, KIR+ CD56+ T cells are even more limited in TREC, TCRVβ, telomere length, and cytokine secretion, but have elevated transcription of NK cytotoxicity-related genes arrb1, ppp3cc, and lamc3, higher degranulation after activation by IL-2/IL-15 and CD3/CD28 antibodies, better killing of cancer cells after cytokine priming, and are mostly KIR2DL2/3+, NKG2D+, NKp46+, CD16+, NKG2C+, CD57+, and 2B4+. Importantly during CMV reactivation after stem cell transplantation, the percentage of KIR+ CD56+ T cells in the patient's blood increased dramatically and was significantly higher (p=0.0021) than in those without viral reactivation. Ex vivo, KIR+ CD56+ T cells demonstrate CMVpp65 tetramer staining, memory response to CMV peptides, and potent lysis of CMVpp65-pulsed target cells dependent on both KIR and TCR specificity. Furthermore, we identified for the first time that KIR– CD56+ T cells are Rorc+ IL-13-secretor. In conclusion, both CD56+ and KIR+ NK-like T-cell subsets are unique in biological and clinical properties and have distinct roles in cancer and infection control. Disclosures: No relevant conflicts of interest to declare.
- Published
- 2012
- Full Text
- View/download PDF
30. 39 Formation of a Lysosomal Disease Testing Network to enhance the delivery of diagnostic services to patients with lysosomal storage disorders
- Author
-
Brian Ulbrich, R. Giugliani, Ed Wraith, M. Calikoglu, Mathias Beck, A. Puga, Uma Ramaswami, Rick A. Martin, Joseph Muenzer, A. Vellodi, Christine M. Eng, Susanne Wendt, Suresh Vijayaraghavan, Paul Harmatz, Marwan Shinawi, and M. Cleary
- Subjects
Endocrinology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Genetics ,Medicine ,Substrate reduction therapy ,Lysosomal storage disorders ,Disease ,Bioinformatics ,business ,Molecular Biology ,Biochemistry - Published
- 2007
- Full Text
- View/download PDF
31. 29 Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome)
- Author
-
A. Vellodi, Christine M. Eng, Paul Harmatz, Susanne Wendt, Joseph Muenzer, R. Giugliani, Marwan Shinawi, Mathias Beck, Rick A. Martin, A. Puga, S. Vijayaraghavan, Uma Ramaswami, B. Ulbrich, Ed Wraith, M. Calikoglu, and M.A. Cleary
- Subjects
medicine.medical_specialty ,Mucopolysaccharidosis II ,business.industry ,Endocrinology, Diabetes and Metabolism ,Hunter syndrome ,Enzyme replacement therapy ,medicine.disease ,Biochemistry ,Gastroenterology ,Endocrinology ,Internal medicine ,Genetics ,medicine ,business ,Molecular Biology - Published
- 2007
- Full Text
- View/download PDF
32. Erratum
- Author
-
Diane Piper, Ana Cristina Puga, Anne Marie Conway, Marwan Shinawi, Brian Ulbrich, Maureen Cleary, Joseph Muenzer, Susanne Wendt, James E. Wraith, Ashok Vellodi, Michael Beck, Suresh Vijayaraghavan, Paul Harmatz, Roberto Giugliani, Alan Kimura, Uma Ramaswami, Muge Gucsavas-Calikoglu, Richard M. Martin, and Christine M. Eng
- Subjects
medicine.medical_specialty ,business.industry ,Mucopolysaccharidosis II ,Idursulfase ,Hunter syndrome ,Enzyme replacement therapy ,medicine.disease ,Clinical study ,Internal medicine ,Immunology ,Medicine ,business ,Genetics (clinical) ,medicine.drug - Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.